BioSpace News Archive

Press Releases

Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial

August 12, 2024
·
10 min read
Press Releases

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

August 12, 2024
·
1 min read
Press Releases

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

August 12, 2024
·
1 min read
Press Releases

60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study

August 12, 2024
·
11 min read
Press Releases

NEXGEL Announces $1,110,000 Registered Direct Offering Led by Insiders

August 12, 2024
·
4 min read
Press Releases

Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as First-Line Treatment of Unresectable/Metastatic Melanoma

August 12, 2024
·
8 min read
Press Releases

Mabwell’s Novel Nectin-4 Targeting ADC 9MW2821 Granted Breakthrough Therapy Designation by China’s NMPA

August 12, 2024
·
5 min read
Press Releases

OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship

August 12, 2024
·
3 min read
Press Releases

Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results

August 12, 2024
·
1 min read
Business

Fortrea Reports Second Quarter 2024 Results

August 12, 2024
·
20 min read